As of March 26, we're $27,100 in the red for the quarter. Donate here to support this vital work
Subscribe here and join over 13,000 subscribers to our free weekly newsletter

Trump picks former pharma exec, ex-Bush official to lead HHS department
Key Excerpts from Article on Website of CNN News


CNN News, November 13, 2017
Posted: November 20th, 2017
http://www.cnn.com/2017/11/13/politics/alex-azar-health-and-...

President Donald Trump on Monday announced he is nominating Alex Azar, a former pharmaceutical company executive and George W. Bush administration official, to succeed Tom Price as the secretary of the Department of Health and Human Services. He previously served as HHS general counsel and deputy secretary for President George W. Bush. Following his time with the administration, he worked for pharmaceutical giant Eli Lilly & Co. [He] became president of Lilly USA in 2012. As part of his role at Lilly USA, Azar was on the board of directors for the Boards of the Biotechnology Industry Organization (BIO), a drug lobbying group. In an October letter, Reps. Raul Grijalva, D-Arizona, Mark Pocan, D-Wisconsin, and Jan Schakowsky, D-Illinois, wrote that under his leadership, Azar's company fought "against federal and state legislation to increase drug pricing transparency." And a lawsuit filed in Massachusetts in early 2017 alleges that the company shot up prices on insulin "in near lock step" with two other pharmaceutical manufacturers. Following Yale Law School, Azar clerked for Supreme Court Justice Antonin Scalia, and later joined the Whitewater independent counsel headed by his "mentor" Ken Starr.

Note: Rather than draining the swamp, Trump continues to deepen the swamp in his administration. Besides this most recent appointment, he has installed Goldman Sachs executives as his Treasury secretary, top economic adviser, deputy national security adviser and chief strategist. Even his top Wall Street regulator is a former attorney for Goldman. For more, see concise summaries of deeply revealing news articles on corruption in government and in the pharmaceutical industry.


Latest News


Key News Articles from Years Past